Proapoptotic effects of Deferasirox on acute myeloid leukemia (AML) cell lines

被引：0
|
作者：
Hinterleitner, C. [1 ]
Malenke, E. [1 ]
Bugl, S. [1 ]
Haap, M. [2 ]
Mueller, M. R. [1 ]
Heissnet, K. [1 ]
Kopp, H. -G [1 ]
机构：
[1] Univ Tubingen, Dept Med 2, Med Oncol Hematol Immunol Rheumatol & Pulmol, Tubingen, Germany
[2] Univ Tubingen, Dept Internal Med, Med Intens Care Unit, Tubingen, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P503
引用
收藏
页码：146 / 146
页数：1
相关论文
共 50 条
  • [31] Editorial: Immunotherapy in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)
    Jamy, Omer
    Zhou, Fuling
    Zeidner, Joshua
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [32] Prevalence and Effects of Polypharmacy on Overall Survival (OS) of Acute Myeloid Leukemia (AML)
    Dhakal, Prajwal
    Lyden, Elizabeth R.
    Muir, Kate-Lynn E.
    Al-Kadhimi, Zaid S.
    Koll, Thuy T.
    Maness, Lori J.
    Gundabolu, Krishna
    Bhatt, Vijaya R.
    BLOOD, 2019, 134
  • [33] Investigation of the effects of dietary supplement Methylsulfonylmethane on apoptosis signals in acute myeloid leukemia cell lines
    Hekmatshoar, Yalda
    Karabay, Arzu Zeynep
    Koc, Asli
    Ozkan, Tulin
    Sunguroglu, Asuman
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 928 - 928
  • [34] Effects of obesity on overall survival (OS) of patients with acute myeloid leukemia (AML).
    Dhakal, Prajwal
    Lyden, Elizabeth
    Lee, Andrea
    Michalski, Joel
    Al-Kadhimi, Zaid S.
    Maness, Lori J.
    Gundabolu, Krishna
    Bhatt, Vijaya Raj
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [35] ACUTE MYOPERICARDITIS AS THE ATYPICAL PRESENTATION OF ACUTE MYELOID LEUKEMIA (AML)
    Teng, Catherine L.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 1) : S358 - S358
  • [36] Synergistic effects of Deferasirox and Imatinib in chronic myeloid leukemia cells
    Kim, Dae Sik
    Kang, Myoung Hee
    Na, Yoo Jin
    Kim, Jung Lim
    Kim, Bo Ram
    Park, Kyong Hwa
    Oh, Sang Cheul
    Seo, Jae Hong
    Choi, Chul Won
    Kim, Jun Suk
    CANCER RESEARCH, 2014, 74 (19)
  • [37] The mTOR inhibitor rapamycin inhibits drug transport in multidrug resistant cell lines and in acute myeloid leukemia (AML) cells.
    Pawarode, A
    O'Loughlin, KL
    Cuviello, NW
    Greco, WR
    Ford, LA
    Minderman, H
    Baer, MR
    BLOOD, 2005, 106 (11) : 435A - 435A
  • [38] FLT3 mutations in acute myeloid leukemia cell lines
    H Quentmeier
    J Reinhardt
    M Zaborski
    H G Drexler
    Leukemia, 2003, 17 : 120 - 124
  • [39] Effect of aplidina (APL) in leukemia cell lines and cells from acute myeloid leukemia
    Grossi, A
    Biscardi, M
    Gavazzi, S
    Balestri, F
    Bonolis, M
    Caporale, R
    Leoni, F
    Jimeno, J
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (07) : 145 - 146
  • [40] Sinusitis as a Presentation of Acute Myeloid Leukemia (AML) and Myeloid Sarcoma (MS)
    Fuentes-Alfaro, Fabiola
    Vargas-Marin, Carolina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S279 - S279
12345